115 related articles for article (PubMed ID: 16110104)
61. Phase III study on the treatment of women with cervical cancer, stage IIB, IIIB, and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corynebacterium parvum: a Gynecologic Oncology Group Study.
DiSaia PJ; Bundy BN; Curry SL; Schlaerth J; Thigpen JT
Gynecol Oncol; 1987 Mar; 26(3):386-97. PubMed ID: 3549476
[TBL] [Abstract][Full Text] [Related]
62. Prognostic significance of c-erbB-2 protein expression in carcinoma of the cervix treated with radiotherapy.
Nishioka T; West CM; Gupta N; Wilks DP; Hendry JH; Davidson SE; Hunter RD
J Cancer Res Clin Oncol; 1999; 125(2):96-100. PubMed ID: 10190316
[TBL] [Abstract][Full Text] [Related]
63. Continuous or split-course combined external and intracavitary radiotherapy of locally advanced carcinoma of the uterine cervix.
Pedersen D; Bentzen SM; Overgaard J
Acta Oncol; 1994; 33(5):547-55. PubMed ID: 7917370
[TBL] [Abstract][Full Text] [Related]
64. Neutron therapy in cervical cancer: results of a phase III RTOG Study.
Maor MH; Gillespie BW; Peters LJ; Wambersie A; Griffin TW; Thomas FJ; Cohen L; Conner N; Gardner P
Int J Radiat Oncol Biol Phys; 1988 May; 14(5):885-91. PubMed ID: 3283085
[TBL] [Abstract][Full Text] [Related]
65. [Unusual site of misinterpreted bone metastases in irradiated stage IIb cervix cancer].
Adamietz IA; Emminger A; Unverferth D
Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):682-4. PubMed ID: 2777056
[TBL] [Abstract][Full Text] [Related]
66. Extended field irradiation in the treatment of patients with cervical carcinoma involving biopsy proven para-aortic nodes.
Brookland RK; Rubin S; Danoff BF
Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1875-9. PubMed ID: 6436200
[TBL] [Abstract][Full Text] [Related]
67. [Hydronephrosis as a prognostic factor for patients of figo IIIB cervical cancer].
Krynicki R; Bidziński M; Wierzba W; Panek G; Jońska J; Lindner B
Ginekol Pol; 2003 Jan; 74(1):32-9. PubMed ID: 12715435
[TBL] [Abstract][Full Text] [Related]
68. CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy.
Metcalfe E; Arik D; Oge T; Etiz D; Yalcin OT; Kabukcuoglu S; Pasaoglu O; Ozalp SS
J Cancer Res Ther; 2018; 14(6):1373-1378. PubMed ID: 30488859
[TBL] [Abstract][Full Text] [Related]
69. The Impact of High-Dose-Rate Brachytherapy: Measuring Clinical Outcomes in the Primary Treatment of Cervical Cancer.
Song J; Alyamani N; Bhattacharya G; Le T; E C; Samant R
Adv Radiat Oncol; 2020; 5(3):419-425. PubMed ID: 32529136
[TBL] [Abstract][Full Text] [Related]
70. The treatment of stage IV carcinoma of cervix by radical dose radiotherapy.
Upadhyay SK; Symonds RP; Haelterman M; Watson ER
Radiother Oncol; 1988 Jan; 11(1):15-9. PubMed ID: 2449706
[TBL] [Abstract][Full Text] [Related]
71. Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma when treated by radiotherapy?
Davidson SE; Symonds RP; Lamont D; Watson ER
Gynecol Oncol; 1989 Apr; 33(1):23-6. PubMed ID: 2495240
[TBL] [Abstract][Full Text] [Related]
72. [Effects of primary radiotherapy on uterine circulation in advanced cervix cancer].
Vavra N; Skodler WD; Barrada M; Kucera H
Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):463-5. PubMed ID: 1889729
[TBL] [Abstract][Full Text] [Related]
73. Carcinoma of uterine cervix with isolated metastasis to fibula and its unusual behavior: report of a case and review of literature.
Pasricha R; Tiwari A; Aggarwal T; Lal P
J Cancer Res Ther; 2006; 2(2):79-81. PubMed ID: 17998682
[TBL] [Abstract][Full Text] [Related]
74. Radiotherapy in the management of cervical cancer in elderly patients.
Lindegaard JC; Thranov IR; Engelholm SA
Radiother Oncol; 2000 Jul; 56(1):9-15. PubMed ID: 10869749
[TBL] [Abstract][Full Text] [Related]
75. Hyperbaric oxygen therapy for carcinoma of the cervix--stages IIB, IIIA, IIIB and IVA: results of a randomized study by the Radiation Therapy Oncology Group.
Brady LW; Plenk HP; Hanley JA; Glassburn JR; Kramer S; Parker RG
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):991-8. PubMed ID: 7028700
[No Abstract] [Full Text] [Related]
76. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix.
Overgaard J; Bentzen SM; Kolstad P; Kjoerstad K; Davy M; Bertelsen K; Mäntyla M; Frankendal B; Skryten A; Löftquist I
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1069-72. PubMed ID: 2649463
[TBL] [Abstract][Full Text] [Related]
77. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome.
Girinsky T; Rey A; Roche B; Haie C; Gerbaulet A; Randrianarivello H; Chassagne D
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1051-6. PubMed ID: 8262826
[TBL] [Abstract][Full Text] [Related]
78. Abdominal radiotherapy for cancer of the uterine cervix and endometrium.
Potish RA
Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1453-8. PubMed ID: 2542196
[TBL] [Abstract][Full Text] [Related]
79. Bilateral radical radiotherapy in a patient with uterus didelphys.
Lee CD; Churn M; Haddad N; Davies-Humphries J; Kingston RK; Jones B
Br J Radiol; 2000 May; 73(869):553-6. PubMed ID: 10884756
[TBL] [Abstract][Full Text] [Related]
80. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.
Girinski T; Pejovic-Lenfant MH; Bourhis J; Campana F; Cosset JM; Petit C; Malaise EP; Haie C; Gerbaulet A; Chassagne D
Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):37-42. PubMed ID: 2912956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
